MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Neurophysiology"

  • 2022 International Congress

    Comparison between clinical and kinematic assessment of bradykinesia

    G. Paparella, A. de Biase, L. Angelini, A. Cannavacciuolo, D. Colella, A. Guerra, D. Alunni Fegatelli, A. Berardelli, M. Bologna (Pozzilli, Italy)

    Objective: To compare the clinical and kinematic assessment of bradykinesia (movement slowness). Background: Bradykinesia may be present not only in Parkinson’s disease (PD), but also…
  • 2022 International Congress

    Early experience using real-world monitoring to inform Parkinson’s management

    W. Chen, L. Kirkby, T. Jansen, G. Philips, T. Haynes, S. Little, J. Jiminez-Shahad, H. Zahed, P. Lin, R. Gilron (San Francisco, USA)

    Objective: To explore the utility of remote patient monitoring, using a combination of brain sensing and objective outcome measurement, in the management of Parkinson’s disease…
  • 2022 International Congress

    Subthalamic tremor-related oscillatory neurons play a role in the generation of Parkinson’s tremor

    P. Zhuang, M. Hallett, D. Meng, Y. Zhang, P. Li, J. Li (Beijing, China)

    Objective: To explore whether subthalamic tremor-related oscillatory neurons is involved in the generation of Parkinson’s tremor. Background: Both the basal ganglia and cerebello-thalamo-cortical circuits appear…
  • 2022 International Congress

    Task-Specific Dystonia is a predominant disorder of Top-Down Sensorimotor integration

    S. Merchant, M. Hallett (Boston, USA)

    Objective: In this study we investigate two neurophysiologic variables testing for central-peripheral and peripheral-central mechanisms of SM integration in a cohort of TSD to evaluate…
  • 2022 International Congress

    Pilot study to investigate the use of in-clinic sensing to identify optimal stimulation parameters for deep brain stimulation therapy in Parkinson’s disease

    S. Lewis, S. Ojemann, D. Kramer, L. Hirt, E. Radcliffe, M. Case, A. Becker, R. Raike, J. Thompson, D. Kern (Boulder, USA)

    Objective: Compare the use of in-clinic sensing functionality and standard of care monopolar review for identifying optimal settings of a deep brain stimulation (DBS) in…
  • 2022 International Congress

    Shared molecular genetic factors influence brain morphometry and Parkinson’s disease risk

    L. Garcia-Marin, P. Reyes, Z. Ceja, N. Ogonowski, B. García-Vilchis, A. Ruiz-Contreras, D. Vazquez-Guevara, S. Alcauter, E. Morelos, A. Medina-Rivera, B. Mitchell, M. Rentería (Brisbane, Australia)

    Objective: To explore the genetic overlap and identify shared genomic regions between brain morphometry and Parkinson’s disease (PD) risk. Background: PD is a genetically complex…
  • 2022 International Congress

    Sigma Absolute Spectral Power is Associated with Depression in Parkinson’s Disease

    A. Memon, C. Catiul, Z. Irwin, J. Pilkington, A. Joop, R. Memon, K. Wood, G. Cutter, S. Miocinovic, A. Amara (Birmingham, USA)

    Objective: This cross-sectional study investigated the relationship between depression and sigma absolute spectral power (9-15 Hz) in the frequency range of sleep spindles during non-rapid…
  • 2022 International Congress

    Effect of clinical levodopa medication cycle on subthalamic beta band power during therapeutic deep brain stimulation in Parkinson’s disease

    L. Hammer, C. Oehrn, S. Cernera, A. Hahn, M. Shcherbakova, C. Smyth, S. Little, P. Starr (San Francisco, USA)

    Objective: To characterize the effect of levodopa medication cycle on subthalamic nucleus (STN) local field potential (LFP) beta-band power in Parkinson’s disease (PD) in the…
  • 2022 International Congress

    Towards a Machine Learning Based Classification System for Hyperkinetic Movement Disorders: Generating a Neurophysiological Feature Set

    E. V.D. Brandhof, S. V.D. Veen, G. Russo, I. Tuitert, J. Dalenberg, M. V.D. Stouwe, J. Elting, M. Biehl, M. de Koning-Tijssen (Groningen, Netherlands)

    Objective: Generating a set of significant neurophysiological features to build a machine learning based diagnostic system for hyperkinetic movement disorders. Background: Hyperkinetic movement disorders cause…
  • 2022 International Congress

    Determination of metabotropic glutamate receptor 2/3 distribution with [3H]-LY-341,495 in Parkinson’s disease patients with visual hallucinations

    D. Bedard, E. Kim, I. Frouni, P. Huot (Montreal, Canada)

    Objective: To determine the distribution and levels of metabotropic glutamate 2/3 (mGlu2/3) receptors in brain tissue from patients with Parkinson’s disease (PD) with visual hallucinations (VHs).…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 26
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley